G.ST Antivirals GmbH
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Holding
- Established
- 2019-10-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy Adults
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- G.ST Antivirals GmbH
- Target Recruit Count
- 64
- Registration Number
- NCT06375772
- Locations
- 🇳🇱
Centre for Human Drug Research, Leiden, Netherlands
Safety and Pharmacokinetic Study of Intranasal 2-DG in Healthy Volunteers
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2023-10-12
- Lead Sponsor
- G.ST Antivirals GmbH
- Target Recruit Count
- 45
- Registration Number
- NCT05314933
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
News
No news found